Skip to main content
    I

    InfuSystems Holdings Inc (INFU)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

    $14.79
    +0.00 (+0.00%)

    Market Cap: $296.30M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    InfuSystems Holdings Inc (INFU) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    InfuSystems Holdings (INFU) has a market cap of $296.30M and an enterprise value of $306.87M. Its trailing P/E of 29.6x is below its 5-year median of 96.1x. Its share count is down 2.14% from a year earlier.

    Total Valuation

    Enterprise value is 3.57% above the market cap, as debt exceeds cash.

    Market Cap$296.30M
    Enterprise Value$306.87M
    Latest price (Nov 17, 2026)$14.79

    Key Dates

    The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 22, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.47% in the quarter ended Sep 30, 2026 and shrank 3.13% a year over 2 years.

    Shares Outstanding19.98M
    Shares Change (YoY)-2.14%
    Shares Change (QoQ)-0.47%
    Share Count Growth (2Y CAGR)-3.13%

    Valuation Ratios

    Sales and book value multiples are 2.0x and 4.6x. Its year-end P/E ranged from 17.9x to 868.0x from 2019 to 2025.

    P/E Ratio29.6x
    Forward P/E31.5x
    P/S Ratio2.0x
    Forward P/S2.0x
    P/B Ratio4.6x
    P/TBV Ratio5.5x
    P/FCF Ratio11.9x
    P/OCF Ratio11.7x
    PEG Ratio0.7

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 11.2x EBITDA and 12.4x free cash flow.

    EV / Earnings32.5x
    EV / Sales2.1x
    EV / EBITDA11.2x
    EV / EBIT21.4x
    EV / FCF12.4x

    Price Statistics

    The stock is up 55.52% over 52 weeks and trades 9.64% above its 50-day average.

    Beta (1Y)0.82
    52-Week Change+55.52%
    1-Month Change+7.64%
    3-Month Change+21.33%
    6-Month Change+52.95%
    5-Year Change-15.39%
    10-Year Change+451.76%
    Total Return (1Y)+55.52%
    Total Return (3Y CAGR)+16.76%
    Total Return (5Y CAGR)-4.35%
    Return vs SPY (1Y)+47.30%
    Max Drawdown (1Y)-23.91%
    Max Drawdown (3Y)-56.84%
    Sharpe Ratio (1Y)0.86
    Correlation with SPY (1Y)0.21
    50-Day Average$13.49
    200-Day Average$10.68
    52-Week Range$7.29 to $15.47
    RSI (14 Days)60.0
    Average Volume (20 Days)160.19K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.68x current liabilities, and total debt is 0.31x shareholder equity.

    Current Ratio2.68x
    Quick Ratio2.39x
    Debt / Equity0.31x
    Debt / EBITDA0.72x
    Debt / FCF0.80x
    Interest Coverage13.98x

    Returns and Efficiency

    Return on invested capital is 12.13% over the last 12 months, against a 5-year average of 6.65%.

    Return on Equity (ROE)14.72%
    Return on Assets (ROA)9.03%
    Return on Invested Capital (ROIC)12.13%
    Return on Capital Employed (ROCE)16.57%
    ROE (5Y Average)4.06%
    ROA (5Y Average)2.23%
    ROIC (5Y Average)6.65%
    Asset Turnover1.42x
    Inventory Turnover11.47x
    Receivables Turnover5.09x
    Cash Conversion Cycle47 days

    Taxes

    Income tax took 29.18% of pretax income over the last 12 months.

    Income Tax (TTM)$3.89M
    Effective Tax Rate29.18%

    Scores

    INFU has an Altman Z-Score of 5.79, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score5.79
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $144.44M over the last 12 months is up 2.40% from the 12 months before.

    Revenue$144.44M
    Revenue Growth (YoY)+2.40%
    Gross Profit$83.26M
    Operating Income$14.20M
    Pretax Income$13.33M
    Net Income$9.44M
    EBITDA$27.34M
    EBIT$14.36M
    Reported EPS (TTM)$0.50

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 61.38% of the $104.52M in total assets.

    Cash and Equivalents$9.11M
    Total Debt$19.69M
    Net Debt$10.58M
    Net Debt Per Share$0.53
    Working Capital$30.04M
    Shareholder Equity$64.15M
    Book Value Per Share$3.21
    Tangible Book Value$54.12M
    Tangible Book Per Share$2.71
    Total Assets$104.52M
    Total Liabilities$40.37M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $454.00K of capital spending, operating cash flow left $24.76M of free cash flow.

    Operating Cash Flow$25.22M
    Capital Expenditures$454.00K
    Free Cash Flow$24.76M
    FCF Per Share$1.24
    Depreciation and Amortization$12.98M
    Share Repurchases$6.27M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 9.83%, against a 5-year average of 4.19%.

    Gross Margin57.64%
    Operating Margin9.83%
    Pretax Margin9.23%
    Net Margin6.54%
    EBITDA Margin18.93%
    EBIT Margin9.94%
    FCF Margin17.14%
    Gross Margin (5Y Average)54.13%
    Operating Margin (5Y Average)4.19%
    Net Margin (5Y Average)1.69%

    Growth

    Revenue grew 9.28% a year over 3 years, and EPS 268.40% a year.

    Revenue Growth (3Y CAGR)+9.28%
    Revenue Growth (5Y CAGR)+8.05%
    EPS Growth (3Y CAGR)+268.40%
    EPS Growth (5Y CAGR)-9.20%
    FCF Growth (3Y CAGR)+12.98%
    FCF Growth (5Y CAGR)+4.45%
    Operating Income Growth (3Y CAGR)+93.16%
    Book Value Per Share Growth (2Y CAGR)+6.40%
    Tangible Book Per Share Growth (2Y CAGR)+8.33%

    Revenue and profit by year

    Dividends and Yields

    INFU does not pay a dividend. Its free cash flow yield is 8.38%.

    Earnings Yield3.38%
    FCF Yield8.38%
    Buyback Yield1.67%
    Shareholder Yield1.67%

    Peer Position

    Against 4 similar companies, INFU has the highest P/E.

    P/E Ratio29.6x vs 23.6x median
    P/S Ratio2.0x vs 1.7x median
    ROIC12.13% vs -20.01% median
    Revenue Growth (Trailing 4 Quarters, YoY)+2.40% vs +13.95% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.63% and EPS growth at 5.83% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.63%
    EPS Growth Forecast (2Y CAGR)+5.83%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INFU

    What is INFU's market cap?

    InfuSystems Holdings has a market cap of $296.30M. Its enterprise value, which adds debt and subtracts cash, is $306.87M.

    What is INFU's P/E ratio?

    InfuSystems Holdings has a trailing P/E ratio of 29.6x and a forward P/E of 31.5x.

    How many shares of INFU are outstanding?

    InfuSystems Holdings has 19.98M shares outstanding. The count is down 2.14% from a year earlier.

    Does INFU pay a dividend?

    No. InfuSystems Holdings does not pay a dividend.

    How much debt does INFU have?

    InfuSystems Holdings has $19.69M of total debt and $9.11M of cash and equivalents, a net debt position of $10.58M.